Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation
- PMID: 30132047
- PMCID: PMC6132702
- DOI: 10.1007/s00204-018-2279-8
Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation
Abstract
Isoflavones are secondary plant constituents of certain foods and feeds such as soy, linseeds, and red clover. Furthermore, isoflavone-containing preparations are marketed as food supplements and so-called dietary food for special medical purposes to alleviate health complaints of peri- and postmenopausal women. Based on the bioactivity of isoflavones, especially their hormonal properties, there is an ongoing discussion regarding their potential adverse effects on human health. This review evaluates and summarises the evidence from interventional and observational studies addressing potential unintended effects of isoflavones on the female breast in healthy women as well as in breast cancer patients and on the thyroid hormone system. In addition, evidence from animal and in vitro studies considered relevant in this context was taken into account along with their strengths and limitations. Key factors influencing the biological effects of isoflavones, e.g., bioavailability, plasma and tissue concentrations, metabolism, temporality (pre- vs. postmenopausal women), and duration of isoflavone exposure, were also addressed. Final conclusions on the safety of isoflavones are guided by the aim of precautionary consumer protection.
Keywords: Breast tissue; Human intervention studies; Isoflavones; Observational studies; Safety evaluation; Thyroid hormone system.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures





Similar articles
-
[Dietary isolated isoflavone supplements for peri- and postmenopausal women: risks and questionable benefits].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Feb;56(2):277-84. doi: 10.1007/s00103-012-1604-2. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013. PMID: 23232539 German.
-
Early life and adult exposure to isoflavones and breast cancer risk.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Apr-Jun;26(2):113-73. doi: 10.1080/10590500802074256. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008. PMID: 18569328 Review.
-
Soy for breast cancer survivors: a critical review of the literature.J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. doi: 10.1093/jn/131.11.3095S. J Nutr. 2001. PMID: 11694655 Review.
-
Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.J Natl Cancer Inst. 2006 Sep 20;98(18):1275-84. doi: 10.1093/jnci/djj356. J Natl Cancer Inst. 2006. PMID: 16985246 Review.
-
Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer.Menopause Int. 2008 Mar;14(1):6-12. doi: 10.1258/mi.2007.007033. Menopause Int. 2008. PMID: 18380954 Clinical Trial.
Cited by
-
Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary Flavonoids.Nutrients. 2020 Aug 14;12(8):2452. doi: 10.3390/nu12082452. Nutrients. 2020. PMID: 32824087 Free PMC article.
-
Thyroid Mediation of the Isoflavone Effects on Osteoporotic Bone: The Endocrine Interference With a Beneficial Outcome.Front Endocrinol (Lausanne). 2019 Oct 11;10:688. doi: 10.3389/fendo.2019.00688. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31681166 Free PMC article. No abstract available.
-
Metabolism of Daidzein and Genistein by Gut Bacteria of the Class Coriobacteriia.Foods. 2021 Nov 9;10(11):2741. doi: 10.3390/foods10112741. Foods. 2021. PMID: 34829025 Free PMC article.
-
Therapeutic Potential of Isoflavones with an Emphasis on Daidzein.Oxid Med Cell Longev. 2021 Sep 9;2021:6331630. doi: 10.1155/2021/6331630. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34539970 Free PMC article. Review.
-
Soy protein supplementation in men following radical prostatectomy: a 2-year randomized, placebo-controlled clinical trial.Am J Clin Nutr. 2021 Apr 6;113(4):821-831. doi: 10.1093/ajcn/nqaa390. Am J Clin Nutr. 2021. PMID: 33564828 Free PMC article. Clinical Trial.
References
-
- Adebamowo CA, Cho E, Sampson L, et al. Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer. Int J Cancer. 2005;114(4):628–633. - PubMed
-
- Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis. 2004;25(9):1649–1657. - PubMed
-
- Andres S, Hansen U, Niemann B, Palavinskas R, Lampen A. Determination of the isoflavone composition and estrogenic activity of commercial dietary supplements based on soy or red clover. Food Funct. 2015;6(6):2017–2025. - PubMed
-
- Beekmann K, Actis-Goretta L, van Bladeren PJ, Dionisi F, Destaillats F, Rietjens IM. A state-of-the-art overview of the effect of metabolic conjugation on the biological activity of flavonoids. Food Funct. 2012;3(10):1008–1018. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical